Paul Hawkins

Dr. Kenneth Macleod, PhD

Kenneth is a Partner at Rosetta Capital, a venture capital firm focussed on the life sciences and medical devices . Ken has over 35 years’ experience in the life sciences sector in a career combining senior operating roles in healthcare companies (Abbott Labs., Serono SA) and life science fund management (SV Health Investors, Paul Capital, …

Dr. Kenneth Macleod, PhD Read More »

Christina Takke, PhD Director

Christina is co-founder and Managing Director of V-Bio Ventures. With more than 20 years of investment experience in European venture capital, Christina was previously a partner with Forbion Capital Partners (formerly ABN AMRO Capital) where she led and managed a series of successful biotech investments since 2001. Christina currently serves on the boards of Confo …

Christina Takke, PhD Director Read More »

Dr. Rafiq Hasan Director

Rafiq is the CEO of Complement Therapeutics, a life sciences company aiming to develop the next generation of complement medicines. Rafiq has pursued a successful career in the pharmaceutical industry globally, including senior positions in ophthalmology with Bayer and Novartis. Most recently as Senior Vice President and Global Head of Ophthalmology at Bayer, Rafiq grew …

Dr. Rafiq Hasan Director Read More »

Oxular at Dry AMD Conference

Oxular’s CMO, Friedrich Asmus, MD, spoke at the Dry AMD Therapeutic Development conference in Boston, presenting Oxular’s “Routine Suprachoroidal Drug Administration and it’s role in Intermediate AMD/GA Therapies”  You can view his presentation here

New Oxular CBO – James Jogerst

OXFORD, UK – November 7, 2022 – Oxular Limited, a clinical-stage retinal therapeutics company developing long-lasting targeted treatments for retinal disorders to improve patients’ vision, today announced the appointment of James “Jim” Jogerst as chief business officer, who will lead the company’s business development strategy, and oversee its current and planned strategic partnerships. Mr. Jogerst …

New Oxular CBO – James Jogerst Read More »

Oxular Sponsors ISU 2022

Oxular is thrilled to sponsor ISU 2022 in Utrecht, The Netherlands, and introduce the Oxulumis® suprachoroidal microcatheter to leading uveitis specialists. Together with Marc D. de Smet, we will host a series of skill transfer labs and provide hands-on instruction for routine suprachoroidal drug administration using Oxulumis®. We look forward to seeing you all there.

Dina Chaya Director

Dina is a partner with NeoMed Management, and Advisor to Omega Funds. She has been investing in the private equity and venture capital healthcare industry in Europe and the US since 2001. Previously at 3i in London and Index Ventures in Geneva, Dina’s successful investments include Endosense, EUSA Pharma, Novexel, and Wilson Therapeutics. Dina serves …

Dina Chaya Director Read More »

Scroll to Top